Scholars Central

EditorialPublished 2013

Interleukin-1 Blockade in Acute Myocardial Infarction and Heart Failure: Ready for Clinical Translation?

Authors: Stefano Toldo, Eleonora Mezzaroma, Antonio Abbate

Translational Medicine

Volume 3 · Issue 1 · Pages 1–5

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The synthesis and release of Interleukin-1 (IL-1) are finely regulated processes necessary for the initiation of an inflammatory response to injury. Release of IL-1α from injured cells and of mature IL-1β from circulating monocytes initiates the local and systemic inflammatory response, respectively. An intense IL-1-dependent response occurs during Acute Myocardial Infarction (AMI) and promotes Heart Failure (HF). In advanced HF, a chronic IL-1β-dependent process alters cardiovascular function leading to impaired performance, poor quality of life and increased morbidity and mortality. Here in reviewing the evidence in preclinical studies; we discuss potential strategies to disrupt IL-1 signaling in AMI and HF, and review the results of the initial pilot clinical trials.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Translational Medicine.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalTranslational Medicine
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Stefano Toldo”
  • BylineArticles whose byline prints “Eleonora Mezzaroma”
  • BylineArticles whose byline prints “Antonio Abbate”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels